各イベント詳細
イベント一覧へ戻る

Matching Drugs to Your DNA: Pharmacogenomics, a Global Effort

17 Jan 2017
Date Tue, 17-Jan-2017
Start 12:00
End 14:00
Venue Grand Hyatt Tokyo
Hall/ Room 2F Drawing Room

The description below is adapted from ACCJ Event Information.

In early 2016, President Barack Obama announced a $215 million national Precision Medicine Initiative including a national database of genetic information of one million people in the United States. What came before this presidential announcement has been the unfolding of a scientific revolution leading to medical treatments for individuals based on their genetic information. Pharmacogenomics links drug treatments to your DNA to develop safer and more effective drug therapy to treat diseases that range from cancer to depression.

Please join the ACCJ Globalization Committee in welcoming the father of pharmacogenomics, Dr. Richard Weinshilboum, and the distinguished Dr. Liewei Wang to speak on past efforts at the Mayo Clinic and their colleagues at institutions around the world. Pharmacogenomics has been able to crack the code to address important issues such as why women with breast cancer develop drug-related toxicity or fail to respond to therapy, and why some children with childhood leukemia develop life-threatening adverse drug reactions. The successes of pharmacogenomics have been an important stepping stone to the establishment of the national Precision Medicine Initiative.

Dr. Weinshilboum and Dr. Wang are in Japan as part of a collaborative relationship with the RIKEN Center for Genomic Medicine in Yokohama under the auspices of the Mayo Pharmacogenomics Research Program.
イベント一覧へ戻る
[メインページへ]
Copyright(C) MedicaLingual Inc. All Rights Reserved.
本サイトの文章・画像の無断転用、転写はご遠慮下さい。